KCINCA PHARM S.L

Hoja B604213· NIF B56518582

VigenteBarcelona
Registered address :
Activity :
Fabricación de productos farmacéuticos de base
Legal form :
Sociedades de responsabilidad limitada
Share capital :
10 000,00 €
Incorporation :
17/11/2023
Director :
Mhamed Knani

Legal information

Legal information for KCINCA PHARM S.L

NIF
Hoja registral
IRUS1000384468783
Legal formSociedades de responsabilidad limitada
Share capital10 000,00 €
Incorporation date17/11/2023
Register referenceTomo 49007 · Folio 36 · Hoja B604213
StatusVigente

Activity

KCINCA PHARM S.L is a Sociedades de responsabilidad limitada with its registered office in Barcelona, Cataluña. Its declared activity is “Fabricación de productos farmacéuticos de base” (CNAE 2110). It was incorporated on 17 November 2023. The Spanish commercial register has published 3 filings for this company, from 17 November 2023 to 17 November 2025, across 3 distinct types of filing. Its registered share capital is 10 000,00 €.

Economic activity (CNAE)

2110 · Fabricación de productos farmacéuticos de base

Corporate purpose

LA ACTIVIDAD DE LABORATORIO FARMACEUTICO: FABRICACION Y CONTROL, DISTRIBUCION, IMPORTACION Y EXPORTACION DE PRODUCTOS FARMACEUTICOS, SANITARIOS Y COSMETICOS. EDIFICACION, COMERCIALIZACION DE ALQUILERES DE VIVIENDA, ETC.

Directors and representatives

Directors

Current

Directors network map

Loading…

Registered actos

  1. Ampliación de capitalPublished 17/11/2025· Registered 07/11/2025· I/A 2
  2. ConstituciónPublished 17/11/2023· Registered 10/11/2023· I/A 1
  3. NombramientosPublished 17/11/2023· Registered 10/11/2023· I/A 1

Capital · events

  1. 17/11/2025Ampliación de capital
    Resulting capital: 10 000,00 € (+7 000,00 €)
  2. 17/11/2023Constitución
    Initial capital: 3 000,00 €

Importes obtenidos del BORME cuando se publican (importe de la operación y capital resultante). Algunos anuncios no lo publican; en ese caso consulte el PDF original.

Timeline (BORME)

  1. 17/11/2025#8919178
    Ampliación de capital
    KCINCA PHARM S.L. Ampliación de capital. Capital: 7.000,00 Euros. Resultante Suscrito: 10.000,00 Euros. Otros conceptos: DECLARACION DE PERDIDA DE UNIPERSONALIDAD. Datos registrales. S 8 , H B 604213, I/A 2 ( 7.11.25).
  2. 17/11/2023#7798144
    ConstituciónNombramientos
    KCINCA PHARM S.L. Constitución. Comienzo de operaciones: 10.10.23. Objeto social: LA ACTIVIDAD DE LABORATORIO FARMACEUTICO: FABRICACION Y CONTROL, DISTRIBUCION, IMPORTACION Y EXPORTACION DE PRODUCTOS FARMACEUTICOS, SANITARIOS Y COSMETICOS. EDIFICACIO

Official documents

Official Registro Mercantil documents that we obtain and deliver to you as PDFs.

Nota informativa mercantil (company extract)

Current registry status: administradores and apoderados with their DNI, objects, capital, registered address and latest accounts filing.

Public

Filed annual accounts

Actual image of the filing for each financial year: balance sheet, profit and loss account and shareholder structure.

Public

Certified articles of association

The company's articles of association in force, certified by the registrador.

Public· Incorporated 2023

Certificate of powers of attorney

Powers in force held by a given apoderado (state their NIF or name).

Public

Certificate of good standing and current officers

Conclusive certificate of existence, good standing and the cargos currently in office.

Public

Certificate of beneficial ownership

The company's official beneficial owners.

Requires a legitimate interest (shareholder, director or obliged entity)

Credit risk report

Commercial credit risk report on the company.

Public

Official documents from Spain's Registro Mercantil · delivered as PDFs. Price set by the official arancel, we send a quote once you request one.

Contact details

WebsitesReserved for registered users
PhoneReserved for registered users
EmailReserved for registered users
Social networks
Full addressRD DE SANT PERE NUM.68 P.3 PTA.1 (BARCELONA), Barcelona

Prospect

Spanish companies in the same line of business — Fabricación de productos farmacéuticos de base — are listed together.